Taking Ozempic or Zepbound? FDA orders warning about rare vision loss risk
34 outletsin 4 languages and 7 countriesFirst reported , latest

Told around the world
People and organizations
Named in this story's headlines. Add any of them to CRM by Hottub; nothing is saved until you press Add there.
- United States Food and Drug AdministrationOrganizationAdd
Every report 35 reports
- FDA orders eye risk warnings for Ozempic, Zepbound
Big News NetworkAE
Add to CRM 
- Προειδοποίηση FDA για κίνδυνο απώλειας όρασης που συνδέεται με φάρμακα GLP-1 όπως το Wegovy και το Zepbound
capital.grGR
Add to CRM
- La FDA pide incluir advertencias sobre los riesgos oculares por uso frecuente de Ozempic y Zepbound
Caracol RadioCO
Add to CRM
- FDA'den Ozempic ve Zepbound için "gözde yan etki" uyarısı
gazeteoksijen.comTR
Add to CRM - FDA warns side effect from GLP-1 drugs like Ozempic and Wegovy can lead to blindness
WNBCUS
Add to CRM
- US FDA orders new eye risk warnings for Ozempic, Zepbound - Taylorville Daily News
taylorvilledailynews.com
Add to CRM - FDA orders new eye risk warnings for Ozempic, Zepbound | Honolulu Star-Advertiser
Honolulu Star-AdvertiserUS
Add to CRM